Timo Pietiläinen
- Co-authors
- P. LipponenS. AaltomaaMatti EskelinenM EskelinenVeli‐Matti KosmaKarí SyrjänenKirsi RopponenJari Kellokoski
- Topics
- Cancer-related Molecular Pathways (5 papers)Global Cancer Incidence and Screening (2 papers)Cervical Cancer and HPV Research (2 papers)
In The Last Decade
Timo Pietiläinen
15 papers receiving 527 citations
Peers
Comparison fields: 5 of 79
- Oncology 266
- Molecular Biology 228
- Cancer Research 142
- Surgery 79
- Pulmonary and Respiratory Medicine 73
Countries citing papers authored by Timo Pietiläinen
This map shows the geographic impact of Timo Pietiläinen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timo Pietiläinen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timo Pietiläinen more than expected).
Fields of papers citing papers by Timo Pietiläinen
This network shows the impact of papers produced by Timo Pietiläinen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timo Pietiläinen. The network helps show where Timo Pietiläinen may publish in the future.
Co-authorship network of co-authors of Timo Pietiläinen
This figure shows the co-authorship network connecting the top 25 collaborators of Timo Pietiläinen. A scholar is included among the top collaborators of Timo Pietiläinen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timo Pietiläinen. Timo Pietiläinen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 41 | |
| 2 | 5 | |
| 3 | 17 | |
| 4 | 10 | |
| 5 | 17 | |
| 6 | 1 | |
| 7 | 35 | |
| 8 | [Interstitial nephritis associated with mesalazine therapy]. | 2 |
| 9 | Reduced nuclear expression of transcription factor AP-2 associates with aggressive breast cancer. | 55 |
| 10 | 36 | |
| 11 | 62 | |
| 12 | 0 | |
| 13 | 52 | |
| 14 | 35 | |
| 15 | 138 | |
| 16 | Expression of c-myc proteins in breast cancer as related to established prognostic factors and survival. | 33 |
About Timo Pietiläinen
Timo Pietiläinen is a scholar working on Oncology, Immunology and Allergy and Cancer Research, having authored 16 papers that have together received 539 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (5 papers), Global Cancer Incidence and Screening (2 papers) and Cervical Cancer and HPV Research (2 papers). The work is most often cited by research in Oncology (266 citations), Cancer Research (142 citations) and Pathology and Forensic Medicine (70 citations). Timo Pietiläinen has collaborated with scholars based in Finland and Sweden. Frequent co-authors include P. Lipponen, S. Aaltomaa, Matti Eskelinen, M Eskelinen, Veli‐Matti Kosma, Veli‐Matti Kosma, Karí Syrjänen, Kirsi Ropponen, Jari Kellokoski and V-M Kosma. Their work appears in journals such as PLoS ONE, The Journal of Urology and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.